Medpacto Signs IIT Contract for Combination Therapy for Melanoma Patients

[Jan 18, 2021] Medpacto Signs Investigator Initiated Clinical Trial Contract for Combination Therapy for Melanoma Patients This clinical trial is a phase 2 clinical trial led by a researcher. A clinical trial of a combination of Vactosertib and Keytruda was conducted in 24 melanoma patients at the Hillman Cancer Center in the University of Pittsburgh Medical Center (UPMC) in the U.S. It is led by Diwakar Davar, MD, Ph.D. at the University of Pittsburgh. This clinical trial is a phase 2 clinical trial led by researchers and will be conducted at the Hillman Cancer Center in the University of Pit..........

원문링크 : Medpacto Signs IIT Contract for Combination Therapy for Melanoma Patients